{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:13:03Z","timestamp":1793261583149,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":1030,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacepopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACEP Open"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1002\/emp2.12487","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T19:04:35Z","timestamp":1628363075000},"page":"e12487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Developing an emergency department order set to treat acute pain in sickle cell disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Yves","family":"Duroseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beenhouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tartania","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaedrea","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Malloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie\u2010Laure","family":"Romney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Shani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jena","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Yermilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1002\/emp2.12487_bb0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/emp2.12487_bb0015","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1002\/emp2.12487_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/gim.2012.128","article-title":"Sickle cell disease incidence among newborns in New York State by maternal race\/ethnicity and nativity","volume":"15","author":"Wang","year":"2013","journal-title":"Genet Med"},{"issue":"4","key":"10.1002\/emp2.12487_bb0025","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1542\/peds.2014-3470","article-title":"Improving the management of vaso\u2010occlusive episodes in the pediatric emergency department","volume":"136","author":"Kavanagh","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/emp2.12487_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajh.20336","article-title":"Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance","volume":"79","author":"Ballas","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1002\/emp2.12487_bb0035","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. Evidence\u2010Based Management of Sickle Cell Disease NHLBI Expert Panel Report. 2014. https:\/\/www.nhlbi.nih.gov\/sites\/default\/files\/media\/docs\/sickle\u2010cell\u2010disease\u2010report%20020816_0.pdf"},{"issue":"3","key":"10.1002\/emp2.12487_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.2014-2874","article-title":"Timing of opioid administration as a quality indicator for pain crises in sickle cell disease","volume":"135","author":"Mathias","year":"2015","journal-title":"PEDIATRICS"},{"issue":"12","key":"10.1002\/emp2.12487_bb0045","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/0009922816674521","article-title":"Pain management for sickle cell disease in the pediatric emergency department: medications and hospitalization trends","volume":"56","author":"Cacciotti","year":"2017","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"10.1002\/emp2.12487_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15436\/2381-1404.15.003","article-title":"Exploring adult care experiences and barriers to transition in adult patients with sickle cell disease","volume":"1","author":"Bemrich\u2010Stolz","year":"2015","journal-title":"Int J Hematol Ther"},{"issue":"5","key":"10.1002\/emp2.12487_bb0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1553-2712.2007.tb01801.x","article-title":"Emergency department management of acute pain episodes in sickle cell disease","volume":"14","author":"Tanabe","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"3","key":"10.1002\/emp2.12487_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/AJP.0b013e3181bed10c","article-title":"A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic","volume":"26","author":"Lazio","year":"2010","journal-title":"Clin J Pain"},{"issue":"5","key":"10.1002\/emp2.12487_bb0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1553-2712.2012.01352.x","article-title":"A new improved accelerated diagnostic protocol safely identifies low\u2010risk patients with chest pain in the emergency department: eARLY RULE\u2010OUT OF ACS","volume":"19","author":"Aldous","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"4","key":"10.1002\/emp2.12487_bb0070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/acem.13343","article-title":"A risk assessment score and initial high\u2010sensitivity troponin combine to identify low risk of acute myocardial infarction in the emergency department","volume":"25","author":"Pickering","year":"2018","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"issue":"12","key":"10.1002\/emp2.12487_bb0075","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.4187\/respcare.04011","article-title":"An asthma protocol improved adherence to evidence\u2010based guidelines for pediatric subjects with status asthmaticus in the emergency department","volume":"60","author":"Miller","year":"2015","journal-title":"Respir Care"},{"issue":"4","key":"10.1002\/emp2.12487_bb0080","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/pbc.24864","article-title":"Use of a clinical pathway to improve the acute management of vaso\u2010occlusive crisis pain in pediatric sickle cell disease: clinical pathway for sickle cell pain","volume":"61","author":"Ender","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1002\/emp2.12487_bb0085","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1553-2712.2012.01330.x","article-title":"Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management: ED sickle cell pain crisis","volume":"19","author":"Tanabe","year":"2012","journal-title":"Acad Emerg Med"},{"key":"10.1002\/emp2.12487_bb0090","unstructured":"Community Care of North Carolina Sickle Cell Task Force. Emergency department Vaso\u2010occlusive crisis management: adults and children. https:\/\/sickleemergency.duke.edu\/sites\/default\/files\/ccnc\u2010voc\u2010protocol.pdf"},{"key":"10.1002\/emp2.12487_bb0095","series-title":"The Rand\/UCLA Appropriateness Method User's Manual","year":"2001"},{"issue":"9","key":"10.1002\/emp2.12487_bb0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2105\/AJPH.74.9.979","article-title":"Consensus methods: characteristics and guidelines for use","volume":"74","author":"Fink","year":"1984","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1002\/emp2.12487_bb0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/qhc.11.4.358","article-title":"Research methods used in developing and applying quality indicators in primary care","volume":"11","author":"Campbell","year":"2002","journal-title":"Qual Saf Health Care"},{"issue":"6","key":"10.1002\/emp2.12487_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020476","article-title":"Using and reporting the delphi method for selecting healthcare quality indicators: a systematic review","volume":"6","author":"Boulkedid","year":"2011","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1002\/emp2.12487_bb0115","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.1995.03530080048040","article-title":"Validity of criteria used for detecting underuse of coronary revascularization","volume":"274","author":"Kravitz","year":"1995","journal-title":"JAMA"},{"issue":"26","key":"10.1002\/emp2.12487_bb0120","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199806253382607","article-title":"The reproducibility of a method to identify the overuse and underuse of medical procedures","volume":"338","author":"Shekelle","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1002\/emp2.12487_bb0125","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/pbc.25024","article-title":"Impact of individualized pain plan on the emergency management of children with sickle cell disease: individualized pain plan","volume":"61","author":"Krishnamurti","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1002\/emp2.12487_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5055\/jom.2017.0382","article-title":"Opioid management strategy decreases admissions in high\u2010utilizing adults with sickle cell disease","volume":"13","author":"Mager","year":"2017","journal-title":"J Opioid Manag"},{"issue":"3","key":"10.1002\/emp2.12487_bb0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5811\/westjem.2016.11.32273","article-title":"A patient\u2010centered emergency department management strategy for sickle\u2010cell disease super\u2010utilizers","volume":"18","author":"Simpson","year":"2017","journal-title":"West J Emerg Med"},{"issue":"2","key":"10.1002\/emp2.12487_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.12879","article-title":"Management of the acute painful crisis in sickle cell disease\u2010 a re\u2010evaluation of the use of opioids in adult patients","volume":"166","author":"Telfer","year":"2014","journal-title":"Br J Haematol"},{"issue":"9088","key":"10.1002\/emp2.12487_bb0145","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(97)08462-6","article-title":"Randomised trial of oral morphine for painful episodes of sickle\u2010cell disease in children","volume":"350","author":"Jacobson","year":"1997","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/emp2.12487_bb0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.annemergmed.2006.06.016","article-title":"A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department","volume":"49","author":"Borland","year":"2007","journal-title":"Ann Emerg Med"},{"issue":"6","key":"10.1002\/emp2.12487_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26332","article-title":"Intranasal fentanyl for initial treatment of vaso\u2010occlusive crisis in sickle cell disease","volume":"64","author":"Fein","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1002\/emp2.12487_bb0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.24948","article-title":"A randomized controlled trial comparing two vaso\u2010occlusive episode (VOE) protocols in sickle cell disease (SCD)","volume":"93","author":"Tanabe","year":"2018","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1002\/emp2.12487_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27420","article-title":"Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis","volume":"65","author":"Payne","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1002\/emp2.12487_bb0170","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.hoc.2018.01.014","article-title":"Key components of pain management for children and adults with sickle cell disease","volume":"32","author":"Brandow","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1002\/emp2.12487_bb0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pbc.21854","article-title":"Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease","volume":"52","author":"Frei\u2010Jones","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1002\/emp2.12487_bb0180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/pbc.23140","article-title":"Outpatient follow\u2010up and rehospitalizations for sickle cell disease patients","volume":"58","author":"Leschke","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/emp2.12487_bb0185","unstructured":"New York State Department of Health. I\u2010STOP\/Prescription Monitoring Program (PMP) Internet System for Tracking Over\u2010Prescribing \/Prescription Monitoring Program. Published March 2017. Accessed March 3, 2020. https:\/\/www.health.ny.gov\/professionals\/narcotic\/prescription_monitoring\/"},{"key":"10.1002\/emp2.12487_bb0190","series-title":"Narcotic Enforcement: Laws and Regulations","year":"2020"}],"container-title":["JACEP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/emp2.12487","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emp2.12487","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115224009111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115224009111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/emp2.12487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T01:55:26Z","timestamp":1737770126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2688115224009111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2688115224009111"],"URL":"https:\/\/doi.org\/10.1002\/emp2.12487","relation":{},"ISSN":["2688-1152"],"issn-type":[{"value":"2688-1152","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing an emergency department order set to treat acute pain in sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"JACEP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/emp2.12487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 THE AUTHORS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"e12487"}}